Literature DB >> 1539591

A truncated dystrophin lacking the C-terminal domains is localized at the muscle membrane.

T R Helliwell1, J M Ellis, R C Mountford, R E Appleton, G E Morris.   

Abstract

A Duchenne muscular dystrophy patient who displayed near-normal dystrophin staining at the sarcolemma with N-terminal, but not with C-terminal, anti-dystrophin monoclonal antibodies was found to have a frameshift deletion of exons 42 and 43. This deletion introduces an early termination codon, and a 225-kD protein was detected by western blotting with N-terminal antibodies only. The results suggest that an N-terminal truncated dystrophin fragment encoded by exon 1-41 is able to associate with the muscle cell membrane. The current idea that the C-terminal domains of dystrophin are important or essential for its integration with the sarcolemma may have to be reexamined in the light of these observations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1539591      PMCID: PMC1684302     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  25 in total

1.  Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.

Authors:  K Arahata; A H Beggs; H Honda; S Ito; S Ishiura; T Tsukahara; T Ishiguro; C Eguchi; S Orimo; E Arikawa
Journal:  J Neurol Sci       Date:  1991-02       Impact factor: 3.181

2.  Specificity of dystrophin analysis improved with monoclonal antibodies.

Authors:  J M Ellis; N T Man; G E Morris; I B Ginjaar; A F Moorman; G J van Ommen
Journal:  Lancet       Date:  1990-10-06       Impact factor: 79.321

3.  Direct diagnosis of carriers of Duchenne and Becker muscular dystrophy by amplification of lymphocyte RNA.

Authors:  R G Roberts; D R Bentley; T F Barby; E Manners; M Bobrow
Journal:  Lancet       Date:  1990 Dec 22-29       Impact factor: 79.321

4.  Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

Authors:  E P Hoffman; R H Brown; L M Kunkel
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

5.  Tissue distribution of the dystrophin-related gene product and expression in the mdx and dy mouse.

Authors:  D R Love; G E Morris; J M Ellis; U Fairbrother; R F Marsden; J F Bloomfield; Y H Edwards; C P Slater; D J Parry; K E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

6.  Monoclonal antibody evidence for structural similarities between the central rod regions of actinin and dystrophin.

Authors:  T M Nguyen; J M Ellis; I B Ginjaar; M M van Paassen; G J van Ommen; A F Moorman; A J Cartwright; G E Morris
Journal:  FEBS Lett       Date:  1990-10-15       Impact factor: 4.124

7.  Immunofluorescence dystrophin study in Duchenne dystrophy through the concomitant use of two antibodies directed against the carboxy-terminal and the amino-terminal region of the protein.

Authors:  M Vainzof; E E Zubrzycka-Gaarn; D Rapaport; M R Passos-Bueno; R C Pavanello; I Pavanello-Filho; M Zatz
Journal:  J Neurol Sci       Date:  1991-02       Impact factor: 3.181

8.  An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.

Authors:  A P Monaco; C J Bertelson; S Liechti-Gallati; H Moser; L M Kunkel
Journal:  Genomics       Date:  1988-01       Impact factor: 5.736

9.  Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin.

Authors:  D E Bulman; E G Murphy; E E Zubrzycka-Gaarn; R G Worton; P N Ray
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

10.  Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies.

Authors:  A H Beggs; E P Hoffman; J R Snyder; K Arahata; L Specht; F Shapiro; C Angelini; H Sugita; L M Kunkel
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

View more
  19 in total

1.  Monoclonal antibodies for dystrophin analysis. Epitope mapping and improved binding to SDS-treated muscle sections.

Authors:  T M Nguyen; I B Ginjaar; G J van Ommen; G E Morris
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

2.  Isolation and characterization of a genomic clone from the murine utrophin locus.

Authors:  U Gangadharan; M K Maconochie; K E Davies; S D Brown
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

Review 3.  The dystrophin superfamily: variability and complexity.

Authors:  E Fabbrizio; F Pons; A Robert; G Hugon; A Bonet-Kerrache; D Mornet
Journal:  J Muscle Res Cell Motil       Date:  1994-12       Impact factor: 2.698

Review 4.  Increasing complexity of the dystrophin-associated protein complex.

Authors:  J M Tinsley; D J Blake; R A Zuellig; K E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

5.  Spectrum of small mutations in the dystrophin coding region.

Authors:  T W Prior; C Bartolo; D K Pearl; A C Papp; P J Snyder; M S Sedra; A H Burghes; J R Mendell
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

6.  Dystrophin As a Molecular Shock Absorber.

Authors:  Shimin Le; Miao Yu; Ladislav Hovan; Zhihai Zhao; James Ervasti; Jie Yan
Journal:  ACS Nano       Date:  2018-11-27       Impact factor: 15.881

7.  Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy.

Authors:  T M Nguyen; G E Morris
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

Review 8.  The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy.

Authors:  Jamie L Marshall; Yukwah Kwok; Brian J McMorran; Linda G Baum; Rachelle H Crosbie-Watson
Journal:  FEBS J       Date:  2013-05-13       Impact factor: 5.542

9.  Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin.

Authors:  K Matsumura; F M Tomé; V Ionasescu; J M Ervasti; R D Anderson; N B Romero; D Simon; D Récan; J C Kaplan; M Fardeau
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  Monoclonal antibodies against the muscle-specific N-terminus of dystrophin: characterization of dystrophin in a muscular dystrophy patient with a frameshift deletion of exons 3-7.

Authors:  T T Le; T M Nguyen; D R Love; T R Helliwell; K E Davies; G E Morris
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.